Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

NT219 is a dual inhibitor, novel small molecule that simultaneously targets IRS1/2 and STAT3. A Phase 1 dose escalation study was concluded as a monotherapy and in combination with cetuximab ...

REHOVOT, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented at ...

“On average, Nepal receives only IRs1.8 billion from the allocated amount, and even that is mostly spent on political gatherings as it is distributed through the Indian Embassy. It does not contribute ...

Grid testing confirmed muscle strength preservation, while gene expression analysis revealed upregulation of PLIN4, GLUT transporters, and IRS1. Notably, cFos mapping demonstrated activation of ...

Operations of IRS1 and IRS2 are independent. For example, observers can set up IRS1 for LR and IRS2 for HR if wanted. Also, as long as the telescope stays at a certain position and the fiber ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented ...

RNA-based fusion NGS panel testing for the improved classification of soft tissue sarcomas: A retrospective analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...

During the neonatal stage, the cardiomyocyte undergoes a constellation of molecular, cytoarchitectural, and functional changes known collectively as cardiomyocyte maturation to increase myocardial ...